FAP and neoplasm: Taken together, FAP+ fibroblasts and SPP1+ macrophages coordinated to remodel ECM and promoted connective tissue proliferation, preventing the infiltration of lymphocytes into the tumor core and thereby reducing the efficacy of programmed death-ligand 1 (PD-L1) blockade immunotherapy.